ArticleCroatian medical journal2026
Systemic mesenchymal stem cell therapy for reduction of inflammatory burden in a patient with juvenile-onset rheumatoid arthritis and dialysis-dependent renal failure.
Dragan Primorac et al.PubMed ↗Full text ↗
No numbers read from the abstract.